IMPROVE bleeding risk score: Difference between revisions
Jump to navigation
Jump to search
Line 42: | Line 42: | ||
|[[Kidney failure|Severe kidney failure]] ([[GFR]] &lt; 30 mL/min/m<sup>2</sup>) | |[[Kidney failure|Severe kidney failure]] ([[GFR]] &lt; 30 mL/min/m<sup>2</sup>) | ||
|2.5 | |2.5 | ||
|- | |||
| rowspan="2" |Liver function | |||
|[[Liver failure]] ([[INR]] &gt; 1.5) | |||
|2.5 | |||
|- | |||
|Normal liver function (INR ≤ 1.5) | |||
|0 | |||
|- | |||
| rowspan="2" |Platelet | |||
|≥ 50x10<sup>9</sup>/L | |||
|0 | |||
|- | |||
|&lt; 50x10<sup>9</sup>/L | |||
|4 | |||
|- | |- | ||
| colspan="2" |Admission to [[ICU]] or [[CCU]] | | colspan="2" |Admission to [[ICU]] or [[CCU]] | ||
Line 53: | Line 67: | ||
|- | |- | ||
| colspan="2" |Prior [[bleeding]] within the last 3 months|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |4 | | colspan="2" |Prior [[bleeding]] within the last 3 months|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |4 | ||
|- | |- | ||
| colspan="2" |Rheumatic disease|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |2 | | colspan="2" |Rheumatic disease|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |2 | ||
|- | |- | ||
| colspan="2" |Active [[malignancy]]|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |2 | | colspan="2" |Active [[malignancy]]|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |2 | ||
|} | |} | ||
==Interpretation== | ==Interpretation== | ||
Revision as of 06:27, 10 February 2019
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Rim Halaby, M.D. [2]
Overview
The IMPROVE bleeding risk score estimates the risk of bleeding among acutely ill hospitalized patients.
IMPROVE Bleeding Risk Score
The IMPROVE bleeding risk score estimates the risk of bleeding among acutely ill hospitalized patients.[1]
IMPROVE Bleeding Risk Score Calculator
Variable | Score | |
---|---|---|
Age | ≥ 85 years | 3.5 |
40-84 years | 1.5 | |
< 40 | 0 | |
Gender | Male | 1 |
Female | 0 | |
Kidney function | Normal kidney function (GFR ≥ 60 mL/min/m2) | 0 |
Moderate kidney failure (GFR 30-59 mL/min/m2) | 1 | |
Severe kidney failure (GFR < 30 mL/min/m2) | 2.5 | |
Liver function | Liver failure (INR > 1.5) | 2.5 |
Normal liver function (INR ≤ 1.5) | 0 | |
Platelet | ≥ 50x109/L | 0 |
< 50x109/L | 4 | |
Admission to ICU or CCU | 2.5 | |
Central venous catheter | 2 | |
Active gastric or duodenal ulcer | 4.5 | |
Prior bleeding within the last 3 months | 4 | |
Rheumatic disease | 2 | |
Active malignancy | 2 |
Interpretation
The IMPROVE risk score for bleeding can be interpreted as such:[1]
- Score ≥7: Increased risk of bleeding
- Score <7: Not increased risk of bleeding
See also
References
- ↑ 1.0 1.1 Decousus H, Tapson VF, Bergmann JF, Chong BH, Froehlich JB, Kakkar AK; et al. (2011). "Factors at admission associated with bleeding risk in medical patients: findings from the IMPROVE investigators". Chest. 139 (1): 69–79. doi:10.1378/chest.09-3081. PMID 20453069.